Wet-Lab Developability and Formulatability Assessment
Coriolis Pharma offers cutting-edge formulatability and developability assessment platform services, tailored for modern biologics drug development challenges. Our formulatability assessment service consists of laboratory-based assessments and can be combined with our in silico assessment to provide early insights into molecule characteristics and potential liabilities, optimize formulations, and mitigate risks.
Designed and executed by our team of experts, it enables early decision-making and derisks the drug development process, ultimately saving time and money in later phases for development.
Empowering informed decisions quickly and efficiently in early stages
Conducting formulatability studies is an essential step in drug development that aims to identify the most promising drug candidates early on, before they enter more extensive clinical testing phases.
Coriolis Pharma’s formulatability assessment makes use of laboratory-based experiments, which can be supported by our computational analysis to provide comprehensive support for clients and accelerate drug development timelines. By combining these approaches, the evaluation process becomes both more efficient and thorough.
While physical testing remains essential to validate predictions and confirm real-world behavior, the combined approach guides the identification of promising lead candidates, thus significantly reducing the number of molecules needing extensive experimental evaluation.
This formulatability assessment is further complemented by a high-throughput preformulation screening platform that systematically explores various excipients and conditions tailored to protein development. The data generated supports informed decision-making aligned with the quality target product profile (QTPP) of the therapeutic molecule, streamlining regulatory submissions and improving product predictability in real-world applications.
Accelerator Platforms
Kick-start your program with our in silico, formulatability assessment and preformulation screening services. Leveraging our extensive scientific expertise, we’ve crafted these platforms to help you identify the optimal strategy from the outset and address potential stage-related risks.
Formulatability Assessment for Your Drug Product
We design developability studies for many biopharmaceutical drug products, including highly concentrated protein formulations and active pharmaceutical ingredients like live virus vaccines and viral vectors that fall under biosafety level 2.
Your Phase
Coriolis designs formulatability (including in silico assessment) and preformulation studies to help you pick the best drug product candidate(s) and/or formulation design from the beginning of your program. This ultimately minimizes program failure risks, speeds up time to market and reduces costs.
Developability and Formulatability Assessment Resources
Talk to Our Experts or Request a Quote
Our expert team is ready to answer your questions and guide you to the services best suited to your program’s modality, stage and challenge. If your needs are well-defined, we’ll begin the quotation process.
INFOGRAPHIC
Driving Success from Preclinical to Commercial Approval & Beyond
A guide for early and late-stage development, commercialization, and lifecycle management
Learn More
